Collegium Pharmaceutical, Inc.
COLL
$28.23
$0.080.28%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.05M | 14.50M | 16.96M | 31.51M | 11.98M |
| Total Depreciation and Amortization | 64.77M | 55.94M | 56.40M | 56.51M | 56.61M |
| Total Amortization of Deferred Charges | 1.08M | 819.00K | 1.28M | 1.34M | 1.36M |
| Total Other Non-Cash Items | 6.92M | 9.71M | 14.58M | -2.42M | 8.36M |
| Change in Net Operating Assets | 13.60M | -23.85M | 33.83M | -8.50M | -5.86M |
| Cash from Operations | 71.32M | 57.11M | 123.05M | 78.44M | 72.44M |
| Capital Expenditure | -496.00K | -270.00K | -689.00K | -188.00K | -65.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -655.40M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 153.31M | 1.90M | -19.38M | -30.68M | -2.85M |
| Cash from Investing | -502.59M | 1.63M | -20.07M | -30.87M | -2.92M |
| Total Debt Issued | 299.50M | -- | 565.18M | -- | -- |
| Total Debt Repaid | -7.25M | -7.25M | -587.12M | -16.15M | -16.15M |
| Issuance of Common Stock | 481.00K | 1.34M | 985.00K | 2.29M | 308.00K |
| Repurchase of Common Stock | -646.00K | -15.43M | -861.00K | -964.00K | -25.53M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | -7.00M |
| Cash from Financing | 292.09M | -21.34M | -21.82M | -14.82M | -48.37M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -139.18M | 37.40M | 81.16M | 32.75M | 21.15M |